Résumé
Objective To analyze the current situation and trend of genital herpes disease burden in China from 1990 to 2019, and to provide a theoretical basis for the prevention and treatment of genital herpes. Methods Using the 2019 Global Burden of Disease database, the trend of the burden of genital herpes disease in China from 1990 to 2019 was analyzed using the Joinpoint software based on the indicators of incidence, disability-adjusted life years (DALY) and disability-lost life years. The ARIMA time series model was established to predict the development trend of genital herpes diseases in China from 2020 to 2024. Results From 1990 to 2019, the incidence of genital herpes in China had a downward trend. The incidence of the disease was mainly concentrated in the age group of 15-49 years old, and the DALY rate in this age group showed a significant upward trend (AAPC=0.73, P < 0.001). The age group of 50-69 years old showed a significant upward trend (AAPC=0.09, P < 0.05). The DALY rate of genital herpes in China showed an increasing trend from 1990 to 2019. Between 1990 and 2019, the overall disease burden of women in China was higher than that of men. The ARIMA model predicted that the incidence of genital herpes and DALY rate in China would continue to increase from 2020 to 2024. Conclusion The disease burden of genital herpes in China is still on the rise. It is necessary to strengthen the safe sexual behavior education and actively carry out health education among young and middle-aged people.
Résumé
Two male patients aged 33 and 38 years with mitochondrial encephalopathy with lactic acidosis and stroke-like episodes (MELAS)admitted in our hospital in 2016 and 2017 were reported.The main symptoms included abdominal pain and distension,numbness and weakness of the limbs.MRI showed mild ventriculomegaly with deepened sulcus and widened cerebral fissure,deepened bilateral cerebellar sulcus and the widened cleavage,atrophy of cerebellum and brainstem,and manifestations of acute cerebral infarction.Gene analysis showed mutation of mitochondrial DNA(mtDNA) A3243G.After definite diagnosis was made,patients reveived coenzyme Q10,ATP and vitamin supplements for improving circulation,and neurotrophic drugs for symptomatic treatment.The symptoms were slightly improved after treatment and two cases were followed-up as outpatients.
Résumé
Object To perform detail studies on different species of Ligusticum L (Uumbelliferae) currently prescribing in Yunnan Province for the purpose to clarify the claotic state of its clinical use Methods By literature retrieval, field and market center inspection and pharmacognostic identification in comparison with those documented in classical literatures to arrive at a reasonable evaluation Results Two varieties of Ligusticum L., the Huanggaoben and Heigaoben were currently in common use in Yunnan Province Huanggaoben, the yellow ligusticum, was originated from Sinodielsia yunnanensis Wolff and Ligusticum delavayi Franch Heigaoben, the balck ligusticum, was oringinated from Ligusticum pteridophyllum Franch Conclusion The study may provide references for the further study and clinical use of this medicinal plant